Patent · US Active

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

US11628175B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Claudio Cafiero · Parma, IT
Leonardo Ortenzi · Parma, IT
Francesca Schiaretti · Parma, IT

Key dates

Filing date	Feb 24, 2021
Grant date	Apr 18, 2023
Priority date	—
Expiry date	Apr 18, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dry powder formulations for inhalation containing a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of an inflammatory and/or obstructive airways disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.